Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
icosapent ethyl (vascepa) (1 trial)
Hyperlipidemia, Familial Combined (Phase 4)
Hyperlipidemias (Phase 4)
Hyperlipoproteinemias (Phase 4)
Hyperlipoproteinemia Type V (Phase 4)
Lipidoses (Phase 4)
Trials (1 total)
Trial APIs (1 total)